Answer
The product information for Pemazyre (pemigatinib) 4.5 mg tablets states that pharmaceutical incompatibilities are “Not applicable.”
Sources for this answer
- Pemazyre 4.5 mg - tabletsIncyte Biosciences UK Ltd · emc · SmPC §6.2 Incompatibilities · Version 6Document updated
Sources checked